Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05685433 · ClinicalTrials.gov registry record · NA
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
A NA study of Overactive Bladder and Urge Incontinence, sponsored by Valencia Technologies Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 20
- Study locations
NCT05685433: Recruiting NA study of Overactive Bladder and Urge Incontinence, sponsored by Valencia Technologies Corporation.
NCT05685433 is a NA study of Overactive Bladder and Urge Incontinence that is actively recruiting participants, run by Valencia Technologies Corporation. The registered enrollment target is 200 participants, roughly in line with the 203-participant average among 46 other Overactive Bladder trials with a reported enrollment target. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05685433, a NA study of Overactive Bladder and Urge Incontinence, is actively recruiting participants, sponsored by Valencia Technologies Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).
Primary Outcome
Proportion of subjects achieving at least a 50% improvement in the number of urgency urinary incontinence episodes on a 3-day voiding diary.
Conditions Studied
Interventions
- DEVICE eCoin Tibial Nerve Stimulation
Study Locations (20)
California
- University of California, Irvine - Irvine
- AIR Research - Los Angeles
- Stanford Health - Stanford
Alabama
- Urology Centers of Alabama - Homewood
- USA Health - Mobile
Iowa
- The Iowa Clinic - Ankeny
- University of Iowa - Iowa City
Kansas
- University of Kansas Medical Center Research Institute, Inc - Kansas City
- Cypress Medical Research - Wichita
Arkansas
- Arkansas Urology - Little Rock
Florida
- Urological Research Network Corp - Hialeah
Georgia
- The Emory Clinic - Atlanta
Illinois
- Rush University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-01-26 |
| Est. Completion | 2031-12 |
| Phase | NA |
What NCT05685433 shows while recruiting
NCT05685433 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 203-participant average among 46 other Overactive Bladder trials with a reported enrollment target.
The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which eCoin Tibial Nerve Stimulation is the first listed.
NCT05685433 names 20 study sites across 15 states, led by California, Alabama, Iowa.
Frequently Asked Questions
What is clinical trial NCT05685433 about?
NCT05685433 is a clinical study titled "A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)". A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).
What is the current status of trial NCT05685433?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-01-26. Estimated completion is 2031-12.
What conditions does trial NCT05685433 study?
This clinical trial studies the following conditions: Overactive Bladder, Urge Incontinence, Urinary Urge Incontinence, Incontinence, Urinary.
What interventions are being tested in trial NCT05685433?
The interventions under investigation include: eCoin Tibial Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05685433?
This trial is sponsored by Valencia Technologies Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05685433 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05685433's enrollment target sits among peer trials
200 13th of 46 higher than 33 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI